Notably, in FXRhiPD-L1lo mouse Lewis lung carcinoma (LLC) tumors, FXR diminished the infiltrating immune cells, especially the cytotoxic CD8+ T cells in tumor microenvironment (TME) (16). The gene discussed is CD8A; the disease is neoplasm.